Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Human Herpesvirus 6A (HHV6A) Quantitative Real-Time PCR Array

  • Read more about Human Herpesvirus 6A (HHV6A) Quantitative Real-Time PCR Array
US Application 61/114,753
Filed on 2008-11-14

Identification Of Novel Liver Cancer Biomarkers From MicroRNA Profiling

  • Read more about Identification Of Novel Liver Cancer Biomarkers From MicroRNA Profiling
US Application 60/855,895
Filed on 2006-11-01

Ratio Based Biomarker Of Survival Utilizing PTEN And Phospho-AKT

  • Read more about Ratio Based Biomarker Of Survival Utilizing PTEN And Phospho-AKT
US Application 61/144,501
Filed on 2009-01-14

Molecular Prediction Of Survival Outcome Of Human Hepatocellular Carcinoma (HCC) Patients By A 'driver'-gene-signature.

  • Read more about Molecular Prediction Of Survival Outcome Of Human Hepatocellular Carcinoma (HCC) Patients By A 'driver'-gene-signature.
US Application 61/198,813
Filed on 2008-11-10

Stratification Of Breast Cancer Patients Based On Chromosome 8p 11-12 Amplification Anti/or EIP4EBP1 Over-expression For Therapeutic Interventions With Rapamycin And Its Analogs Against Local Advanced And Metastatic Breast Cancer

  • Read more about Stratification Of Breast Cancer Patients Based On Chromosome 8p 11-12 Amplification Anti/or EIP4EBP1 Over-expression For Therapeutic Interventions With Rapamycin And Its Analogs Against Local Advanced And Metastatic Breast Cancer
US Application 61/152,920
Filed on 2009-02-16

Human Monoclonal Antibodies Against Hendra And Hipah

  • Read more about Human Monoclonal Antibodies Against Hendra And Hipah
US Application 60/718,902
Filed on 2005-09-20

Human Monoclonal Antibodies Against Hendra And Hipah

  • Read more about Human Monoclonal Antibodies Against Hendra And Hipah
US Application 60/678,547
Filed on 2005-05-05

Human Monoclonal Antibodies Against Hendra And Hipah.

  • Read more about Human Monoclonal Antibodies Against Hendra And Hipah.
US Application 60/661,766
Filed on 2005-03-14

MiR-21 Profiling as Predictor of Poor Prognosis and Resistance to Therapy of Colon Cancer

  • Read more about MiR-21 Profiling as Predictor of Poor Prognosis and Resistance to Therapy of Colon Cancer
US Application 61/067,495
Filed on 2008-02-28

MicroRNA Expression Pattern Associated With Colon Adenocarcinoma And Which Predicts Poor Prognosis And Response To Chemotherapy

  • Read more about MicroRNA Expression Pattern Associated With Colon Adenocarcinoma And Which Predicts Poor Prognosis And Response To Chemotherapy
US Application 60/932,736
Filed on 2007-06-01

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 125
  • Page 126
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • Page 131
  • Page 132
  • Page 133
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health